drugset / Trial / NCT06420388
2% Lidocaine Gel in Reducing Postoperative Pain Following Haemorrhoidectomy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study is a randomized, double-blind, controlled trial evaluating the efficacy of 2% lidocaine gel in reducing postoperative pain and analgesic consumption after haemorrhoidectomy. 222 patients undergoing Ferguson haemorrhoidectomy will be randomly assigned to receive either 2% lidocaine gel or a non-anaesthetic lubricant gel control. Pain scores using a visual analog scale (VAS) will be assessed at 12 and 24 hours, and 2, 3, and 7 days postoperatively. Analgesic consumption will also be measured.
Timeline
- Start
- 2023-05-01
- Primary completion
- 2024-07-01
- Completion
- 2024-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 5 ml | Topical |
| Background | Acetaminophen | Small molecule | 500 mg | Oral |
| Background | Celecoxib | Other / unclassified | 200 mg | Oral |
| Background | Parecoxib | Small molecule | 40 mg | Intravenous |
Indications
No indication recorded.